How would you treat a patient with hepatoid adenocarcinoma of gastric origin progressing on FOLFOX+nivolumab and high PD-L1?

PD-L1 100% for this specific scenario

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

What treatment options would you consider for an anorectal adenocarcinoma following long course chemoRT, mFOLFIRINOX, and APR followed by an incomplete re-resection of a local recurrence?

Do you always send SDHB by IHC for workup of GIST or is NGS that includes SDHB sufficient?

What is your preferred initial treatment for metastatic GE junction adenocarcinoma that's HER2 negative and CLDN 18.2 >75% with PD-L1 CPS 1-4%?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.